Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,807 | 17,064 | 25,422 | 35,521 | 49,326 |
| Receivables | 6,955 | 7,990 | 12,891 | 9,536 | 13,130 |
| Inventories | 2,461 | 3,242 | 3,173 | 3,087 | 2,859 |
| TOTAL | $44,625 | $31,684 | $43,909 | $51,088 | $68,314 |
| Non-Current Assets | |||||
| PPE Net | 6,873 | 7,728 | 8,457 | 9,059 | 9,726 |
| Intangibles | 102 | 7,402 | 7,416 | 428 | 153 |
| Other Non-Current Assets | 11,284 | 3,609 | 3,764 | 3,912 | 286 |
| TOTAL | $18,259 | $18,739 | $19,637 | $13,399 | $10,165 |
| Total Assets | $62,884 | $50,423 | $63,546 | $64,487 | $78,479 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,664 | 16,987 | 13,390 | 14,090 | 12,274 |
| Accrued Expenses | 8,569 | N/A | N/A | N/A | 5,475 |
| Other current liabilities | 1,450 | N/A | N/A | N/A | N/A |
| TOTAL | $21,104 | $18,373 | $14,882 | $15,362 | $18,555 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,329 | 60,346 | 61,505 | 60,922 | 60,338 |
| Deferred Revenues | 693 | 722 | 803 | 663 | 806 |
| Other Non-Current Liabilities | 52,315 | 4,529 | 4,680 | 4,823 | 1,360 |
| TOTAL | $90,277 | $68,569 | $70,052 | $69,954 | $66,046 |
| Total Liabilities | $111,381 | $86,942 | $84,934 | $85,316 | $84,601 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,214 | 33,620 | 33,620 | 33,583 | 33,582 |
| Common Shares | 35 | 34 | 34 | 34 | 34 |
| Retained earnings | -186,257 | -165,889 | -149,338 | -147,004 | -130,474 |
| TOTAL | $-48,497 | $-36,519 | $-21,388 | $-20,829 | $-6,122 |
| Total Liabilities And Equity | $62,884 | $50,423 | $63,546 | $64,487 | $78,479 |